Reminder: DUA and VRDC access needs to be extended or renewed annually. Read more.
SAS Name
PRFMNC_PRD
OCM six-month performance period. Episodes of care were organized by performance periods, which are the six-month periods of time during which a cohort of episodes terminated and was reconciled together.
| Code | Code value |
|---|---|
| 3 | Episodes beginning July 2, 2017–January 1, 2018 |
| 4 | Episodes beginning January 2, 2018–July 1, 2018 |
| 5 | Episodes beginning July 2, 2018–January 1, 2019 |
| 6 | Episodes beginning January 2, 2019–July 1, 2019 |
| 7 | Episodes beginning July 2, 2019–January 1, 2020 |
| 8 | Episodes beginning January 2, 2020–July 1, 2020 |
| 9 | Episodes beginning July 2, 2020–January 1, 2021 |
| 10 | Episodes beginning January 2, 2021–July 1, 2021 |
| 11 | Episodes beginning July 2, 2021–December 31, 2021 |
In OCM, episodes are initiated on the date of service for an initial Part B chemotherapy drug claim with a corresponding cancer diagnosis on the claim, or on the fill date for an initial Part D chemotherapy drug claim with a corresponding Part B claim for cancer on the date of, or in the 59 days preceding, the drug claim. Episodes continued for six months after the triggering chemotherapy event, as long as the beneficiary met eligibility requirements for all six months. Beneficiaries who continued to receive chemotherapy after completing the six-month episode initiated a new episode. Data reported for the first two OCM performance periods have not been shared because obstacles were encountered that made the data reported questionable in accuracy and reliability.
SOURCE: Oncology Care Model Data Registry